Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Marinus Pharmaceuticals, Inc.
13G/A
MRNS · 56854Q200
|
0% |
2/12/2025
Event 12/31/2024
|
|||
| Sofinnova Investments, Inc. | 0% | ||||
| Sofinnova BioEquities GP LLC | 0% | ||||
| James Healy | 0% | ||||
| Eric Delbridge | 0% | ||||